DeepMed Research

Université Catholique de Louvain

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1425-01-01

Employees: 5K

Market Cap: -

Website: http://www.uclouvain.be

Clinical Trials

Effect of HABIT-ILE on Visuo-spatial Attention of Children With Unilateral CP

Not Applicable

Completed

Conditions: Cerebral Palsy

Interventions: Behavioral: HABIT-ILE without prismatic adaptation
Behavioral: HABIT-ILE with prismatic adaptation

First Posted Date: 2016-10-26

Last Posted Date: 2020-12-07

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 35

Registration Number: NCT02946086

Locations: 🇧🇪
Bleyenheuft Yannick, Brussels, Belgium

Frailty and Postoperative Shock

Completed

Conditions: Elderly
Frailty

First Posted Date: 2016-02-01

Last Posted Date: 2016-02-01

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 53

Registration Number: NCT02669927

Changes in Everydaylife Activity of Children With CP During HABIT-ILE

Not Applicable

Completed

Conditions: Cerebral Palsy

Interventions: Other: HABIT-ILE
Other: Control

First Posted Date: 2016-01-29

Last Posted Date: 2020-12-21

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 40

Registration Number: NCT02667613

Locations: 🇧🇪
Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium

Comparison of Two Manual Therapy Techniques on Ankle Dorsiflexion

Not Applicable

Completed

Conditions: Ankle Stiffness

Interventions: Other: osteopathic mobilization
Other: mobilization with movement

First Posted Date: 2016-01-12

Last Posted Date: 2016-03-18

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 40

Registration Number: NCT02653807

Locations: 🇧🇪
IREC/CARS - Tour Pasteur - Saint-Luc Hospital, Brussels, Belgium

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

Phase 4

Conditions: Kidney Diseases

Interventions: Drug: Advagraf

First Posted Date: 2014-12-08

Last Posted Date: 2014-12-08

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 150

Registration Number: NCT02311010

Locations: 🇧🇪
Cliniques universitaires Saint Luc Université Catholique de Louvain, Brussels, Belgium

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2014-12-04

Last Posted Date: 2019-01-23

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 3133

Registration Number: NCT02307799

Locations: 🇷🇺
Family medicine center, Saint Petersburg, Russian Federation
🇷🇺
City Policlinic Number 2, Arkhangelsk, Russian Federation

How Are Changing the Practices After the Introduction of the Pleth Variability Index? A Before/After Survey.

Completed

Conditions: Fluid Management

Interventions: Device: PVI

First Posted Date: 2014-10-22

Last Posted Date: 2021-04-28

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 88

Registration Number: NCT02271841

Locations: 🇧🇪
Cliniques universitaires Saint-Luc, Brussels, Belgium

Temocillin Pharmacokinetics in Paediatrics

Phase 4

Conditions: Infection
Liver Dysfunction
Urinary Tract Infection

Interventions: Drug: Temocillin

First Posted Date: 2014-10-09

Last Posted Date: 2022-05-31

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 45

Registration Number: NCT02260102

Locations: 🇧🇪
Cliniques universitaires St-Luc, Bruxelles, Belgium

A Randomized Placebo Controlled Trial on the Efficacy of Sustained Natural Apophyseal Glide (SNAG) in Low Back Pain Patients

Not Applicable

Completed

Conditions: Low Back Pain
Manual Therapy
Sustained Natural Apophyseal Glide (SNAG)

Interventions: Device: Sham
Device: SNAG

First Posted Date: 2014-05-01

Last Posted Date: 2014-08-15

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 32

Registration Number: NCT02128607

Locations: 🇧🇪
READ LAB / Tour Pasteur / Saint-Luc Hospital, Brussels, Belgium

Ketorolac in Breast Cancer Surgery

Phase 3

Completed

Conditions: Curative Breast Cancer Surgery
Inflammatory Positive/Negative Status
Pre Surgical Incision Administration

Interventions: Drug: Placebos
Drug: Ketorolac 30 mg IV

First Posted Date: 2013-03-07

Last Posted Date: 2020-04-07

Lead Sponsor: Université Catholique de Louvain

Target Recruit Count: 203

Registration Number: NCT01806259

Locations: 🇧🇪
Cliniques universitaires Saint-Luc, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy